-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

RNA:m5C Methyltransferases and RNA Epigenetics-Mediated Drug Resistance in Leukemia

Scientific Workshop on Therapy Resistance Mechanisms in Blood Malignancies
Program: Scientific Workshops
Session: Post-Transcriptional Mechanisms Controlling Therapy Response
Friday, December 8, 2023, 2:45 PM-3:29 PM

Jason Xiaojun Cheng, MD, PhD

University of Chicago, Chicago, IL

Disclosures: Cheng: ChromoRx: Current equity holder in private company.

<< Previous Presentation | Next Presentation